
This device is designed to assist healthcare professionals in analyzing fundus images for the early detection of key retinal conditions.

This device is designed to assist healthcare professionals in analyzing fundus images for the early detection of key retinal conditions.

What do ophthalmologists consider the key advancements in treating glaucoma over the last several decades?

The researchers reported a “notable” correlation which could serve as a predictive biomarker

Emerging technologies, such as remote tonometry and genetic risk scoring, are revolutionizing glaucoma care by enabling earlier detection, personalized management, and more efficient use of resources.

If approved, the drug will be branded as LYTENAVA.

We asked ophthalmologists what stands out to them in the history of treating glaucoma and where future treatments might be heading.

The procedure offers a renewed approach to suprachoroidal drainage, with potential for both combined and standalone glaucoma surgery.

In the group of new appointees, the organisation welcomed community members who are passionate about advocacy and education

Researchers indicated that pediatric patients with Leber congenital amaurosis experienced improvements in vision.

The intent is that the board provide strategic guidance and expert insights to support the development of the company’s programs and science.

This year, the European Society of Cataract and Refractive Surgeons has partnered with the Hellenic Society of Intraocular Implant and Refractive Surgery

More respondents reported experiencing sexual harassment than in a survey conducted 5 years earlier

RPESC-RPE-4W is a cell product derived from adult retinal pigment epithelial stem cells.

The Elios procedure increased aqueous humor outflow in all investigated eyes, but further studies are needed to correlate these improvements with its clinical efficacy.

A systematic review and meta-analysis highlights the safety and efficacy of excimer laser trabeculostomy as an implant-free MIGS procedure for managing open-angle glaucoma and ocular hypertension, either alone or in combination with cataract surgery.

At the Envision Summit 2025 in San Juan, Puerto Rico, Sara Wester, MD, discussed the Women Leaders in Eye Health session at the conference and the donation from Orbis that supported the session.

The company announced it has successfully started imaging patients with its first prototype of its device using both near-infrared and green modes.

Ophthalmologist offers insights into the value of technology in diabetic retinopathy.

The device offers a shortened procedure time and efficient, effective SMILE for patients with myopia, with or without astigmatism.

The Visumax 800 boasts a faster laser pulse repetition rate for shorter procedures

The initiative marks the second annual ROP Awareness week, running from 24 February to 2 March, 2025

Bonnie Henderson, MD, founder and program director of the EnVision Summit, talked with Ophthalmology Times about the evolution of the conference and how it brings optometrists and ophthalmologists together to learn, discuss shared problems, and facilitate co-management in a family-friendly environment.

Italian investigators reported that ocular surface conditions such as dry eye disease are key factors in perioperative outcomes, even when patients achieve 20/20 vision.

The funding will help further the glaucoma program alongside new board member Carol Gallagher.

Monofocal IOLs, along with advanced phacoemulsification technology, offer tailored solutions.

Arctic Vision has a commercial collaboration agreement with Santen Pharmaceutical Co., Ltd. to commercialize ARVN001 for the treatment of UME.

Researchers indicated that paediatric patients with Leber congenital amaurosis experienced improvements in vision

The biosimilar to aflibercept (Eylea) had already received approval in the EU and US.

Incoming directors bring diverse expertise to help the ASO protect ophthalmic care and advocate for patients.

The researchers successfully tested the robot using enucleated pig eyes.